Shapypro. Shape your Project

Biocidal Product Registration Under BPR (EU 528/2012)

Biocidal product registration with a structured regulatory approach

Placing a biocidal product on the European market requires a clear understanding of the regulatory framework established under Regulation (EU) No 528/2012. At SHAPYPRO, we support companies in approaching biocidal product registration through technical review, regulatory interpretation, dossier consistency, and documentation support.

 

A structured approach to BPR compliance

Biocidal product registration involves the evaluation of active substances, product composition, efficacy, intended uses, human health risks, environmental risks, labelling obligations, and supporting documentation. A weak or incomplete submission may lead to delays, requests for additional information, or refusal of authorisation.

Our role is to help companies approach this process with greater clarity, technical consistency, and regulatory alignment.

01

Active Substances
Detailed review of active substance status, identity, impurities, and regulatory relevance for the intended Product Type.

02

Efficacy Standards
Assessment of available efficacy data and technical support to verify whether product claims are properly supported.

03

Risk Management
Consideration of human health and environmental aspects, together with labelling and dossier consistency requirements.

 

What is considered a biocidal product?

Under the Biocidal Products Regulation, a biocidal product is a substance or mixture intended to destroy, deter, render harmless, prevent the action of, or otherwise control harmful organisms by chemical or biological means.

Biocidal products are classified into different Product Types (PTs), grouped into four main categories:

  • Disinfectants
  • Preservatives
  • Pest control
  • Other specialised biocidal products

Correct classification is one of the first critical steps in defining the registration strategy.

 

Our biocidal product registration support

We provide technical and regulatory support for companies that need to register, assess, or prepare a biocidal product for the European market.

Regulatory status
Verification of product classification, biocidal scope, and relevance of active substance inclusion under BPR.
PT identification
Product Type (PT) identification and regulatory route analysis for the correct strategy definition.
Active substance review
Review of active substance status under BPR and assessment of regulatory implications.
Authorisation strategy
Support in defining the most appropriate authorisation route according to product profile and objectives.
Efficacy studies
Technical review of efficacy studies and supporting evidence related to the intended use and claims.
Documentation review
Preparation and review of technical documentation, including identification of gaps and missing elements.
Dossier consistency
Review of consistency between claims, intended use, labelling, and dossier content.
Workflow support
Support in coordination with testing and regulatory workflows to improve process efficiency.

A well-defined strategy at the beginning of the process can help reduce delays, avoid unnecessary testing, and improve dossier consistency.

 

Authorisation routes under the BPR

Depending on the product and commercial objective, different regulatory routes may apply:

National Authorisation

Suitable when the product is intended for one Member State as a first market entry route.

Mutual Recognition

Used to extend an existing national authorisation to other EU Member States, either in parallel or in sequence.

Union Authorisation

A single authorisation route valid across the EU for eligible product types, requiring a strong and well-prepared dossier.

We help evaluate which route is more appropriate based on the product profile, intended use, and market strategy.

 

What does a biocidal product dossier typically require?

Although requirements vary depending on the product and route, a biocidal product registration dossier typically includes:

  • Qualitative and quantitative composition
  • Chemical identity of the substances
  • Relevant impurities
  • Manufacturing method
  • Efficacy data relevant to the intended use
  • Human health risk assessment
  • Environmental risk assessment
  • Classification and labelling requirements
  • An up-to-date Safety Data Sheet

This process requires scientific rigour and documentary consistency.

 

Common issues that delay registration

Many registration problems begin long before submission. Some of the most common issues include:

  • Incorrect Product Type selection
  • Use claims not supported by the available efficacy data
  • Inconsistencies between dossier, label, and intended use
  • Underestimation of environmental requirements
  • Lack of clarity regarding active substance approval status
  • Poor planning of documentation and testing needs

Identifying these issues early can significantly improve the efficiency of the process.

 

Why work with SHAPYPRO?

SHAPYPRO supports regulatory and technical projects with a practical and scientifically grounded approach. We help companies organise complex information, review technical requirements, and move forward with stronger documentation and better regulatory positioning.

Our work is focused on clarity, technical rigour, and fit-for-purpose support throughout the registration process.

Technical review
Regulatory interpretation
Efficacy-focused support
Documentation consistency

 

Need support with a biocidal product registration project?

If you are preparing a new biocidal product for the EU market, reviewing an existing regulatory strategy, or assessing dossier requirements under BPR (EU 528/2012), SHAPYPRO can support your next steps.

Contact SHAPYPRO